Sequelae of COVID-19 With Focus on Exercise Capacity and Underlying Mechanisms

NCT05118711 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 128

Last updated 2023-02-10

No results posted yet for this study

Summary

The project is designed as a cross-sectional study and aims to examine long-term consequences of coronavirus disease 2019 (COVID-19) for selected bio-behavioural parameters while taking the disease course severity into account.

Conditions

  • Patients Post-COVID-19
  • Controls

Interventions

DIAGNOSTIC_TEST

Cardiorespiratory fitness

Cardiopulmonary exercise testing

DIAGNOSTIC_TEST

Lung function

Body plethysmography

DIAGNOSTIC_TEST

Muscular strength and balance tests

Handgrip strength test, mid-thigh pull test and standing balance test in static tandem stance

DIAGNOSTIC_TEST

Micro- and macrovascular endothelial function and cardiac function

Measurement of flow-mediated dilation, static and dynamic retinal vessel analysis, echocardiography

DIAGNOSTIC_TEST

Blood sampling and analysis

Blood sampling by venepuncture

DIAGNOSTIC_TEST

Physical activity

Physical activity surveillance using accelerometers

DIAGNOSTIC_TEST

Questionnaires

Global physical activity questionnaire (GPAQ), short-form 8 health survey (SF-8), barriers to physical activity, fatigue assessment scale (FAS), modified medical research council dyspnea scale (mMRC), depression, anxiety, and stress scale (DASS21), post-COVID-19 syndrome symptoms

DIAGNOSTIC_TEST

Body composition

Dual-energy x-ray absorptiometry (DXA)

Sponsors & Collaborators

  • Arno Schmidt-Trucksäss

    lead OTHER

Principal Investigators

  • Arno Schmidt-Trucksäss, Prof. · Department of Sport, Exercise and Health, University of Basel, Basel, Switzerland

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-03
Primary Completion
2024-03-31
Completion
2024-03-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05118711 on ClinicalTrials.gov